BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19350049)

  • 1. Differing effects of exogenous or endogenous cathelicidin on macrophage toll-like receptor signaling.
    Pinheiro da Silva F; Gallo RL; Nizet V
    Immunol Cell Biol; 2009; 87(6):496-500. PubMed ID: 19350049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharide.
    Li G; Domenico J; Jia Y; Lucas JJ; Gelfand EW
    Int Arch Allergy Immunol; 2009; 150(2):122-32. PubMed ID: 19439978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan.
    Doz E; Rose S; Nigou J; Gilleron M; Puzo G; Erard F; Ryffel B; Quesniaux VF
    J Biol Chem; 2007 Sep; 282(36):26014-25. PubMed ID: 17617634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling events leading to peroxiredoxin 5 up-regulation in immunostimulated macrophages.
    Abbas K; Breton J; Picot CR; Quesniaux V; Bouton C; Drapier JC
    Free Radic Biol Med; 2009 Sep; 47(6):794-802. PubMed ID: 19540914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moesin-induced signaling in response to lipopolysaccharide in macrophages.
    Zawawi KH; Kantarci A; Schulze-Späte U; Fujita T; Batista EL; Amar S; Van Dyke TE
    J Periodontal Res; 2010 Oct; 45(5):589-601. PubMed ID: 20546116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production via down-regulation of MyD88 expression.
    Noman AS; Koide N; Hassan F; I-E-Khuda I; Dagvadorj J; Tumurkhuu G; Islam S; Naiki Y; Yoshida T; Yokochi T
    Innate Immun; 2009 Feb; 15(1):33-41. PubMed ID: 19201823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of cathelicidin-related antimicrobial peptide in murine osteoclastogenesis.
    Horibe K; Nakamichi Y; Uehara S; Nakamura M; Koide M; Kobayashi Y; Takahashi N; Udagawa N
    Immunology; 2013 Nov; 140(3):344-51. PubMed ID: 23826736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of TLR4-induced IκB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein.
    Ray M; Yu S; Sharda DR; Wilson CB; Liu Q; Kaushal N; Prabhu KS; Hankey PA
    J Immunol; 2010 Dec; 185(12):7309-16. PubMed ID: 21078906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor progression locus 2-dependent oxidative burst drives phosphorylation of extracellular signal-regulated kinase during TLR3 and 9 signaling.
    Kuriakose T; Rada B; Watford WT
    J Biol Chem; 2014 Dec; 289(52):36089-100. PubMed ID: 25378393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tristetraprolin regulates necroptosis during tonic Toll-like receptor 4 (TLR4) signaling in murine macrophages.
    Ariana A; Alturki NA; Hajjar S; Stumpo DJ; Tiedje C; Alnemri ES; Gaestel M; Blackshear PJ; Sad S
    J Biol Chem; 2020 Apr; 295(14):4661-4672. PubMed ID: 32094226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MyD88-dependent Toll-like receptor signaling is required for murine macrophages response to IS2.
    Li H; Kim WJ; Jiang J; Lee SH; Youn HS; Moon EY; Kim TJ; Ye SK; Ryu JH; Kang TB; Koppula S; Park PJ; Choi DK; Lee KH
    Int Immunopharmacol; 2011 Oct; 11(10):1578-83. PubMed ID: 21628003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOCS1 regulates the IFN but not NFkappaB pathway in TLR-stimulated human monocytes and macrophages.
    Prêle CM; Woodward EA; Bisley J; Keith-Magee A; Nicholson SE; Hart PH
    J Immunol; 2008 Dec; 181(11):8018-26. PubMed ID: 19017994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced TLR4 reactivity following injury is mediated by increased p38 activation.
    Maung AA; Fujimi S; Miller ML; MacConmara MP; Mannick JA; Lederer JA
    J Leukoc Biol; 2005 Aug; 78(2):565-73. PubMed ID: 15857937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages.
    Fernandez-Lizarbe S; Pascual M; Gascon MS; Blanco A; Guerri C
    Mol Immunol; 2008 Apr; 45(7):2007-16. PubMed ID: 18061674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition.
    Erridge C; Kennedy S; Spickett CM; Webb DJ
    J Biol Chem; 2008 Sep; 283(36):24748-59. PubMed ID: 18559343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse Bone Marrow Sca-1
    Naik SK; Padhi A; Ganguli G; Sengupta S; Pati S; Das D; Sonawane A
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28739828
    [No Abstract]   [Full Text] [Related]  

  • 18. Innate immune responses to bacterial ligands in the peripheral human lung--role of alveolar epithelial TLR expression and signalling.
    Thorley AJ; Grandolfo D; Lim E; Goldstraw P; Young A; Tetley TD
    PLoS One; 2011; 6(7):e21827. PubMed ID: 21789185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-kappaB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signaling.
    Sacre SM; Lundberg AM; Andreakos E; Taylor C; Feldmann M; Foxwell BM
    J Immunol; 2007 Feb; 178(4):2148-54. PubMed ID: 17277119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
    Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
    J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.